Pyrotinib Plus Trastuzumab After First-line TH (P) Treatment With HER-2 Positive Breast Cancer
Clinical trial NCT05255523 · UNKNOWN
Trial details
- NCT number
- NCT05255523
- Sponsor
- Fujian Medical University Union Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-20
- Primary completion
- 2023-11-05
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.